Pharmaceutical giant Novo Nordisk plans to lay off 215 workers at its Plainsboro facility in mid-February 2027, according to a Worker Adjustment and Retraining Notification (WARN) notice.
The upcoming job cuts mark the latest round of reductions for the company in New Jersey, coming after Novo Nordisk announced in September that more than 100 employees would lose their jobs at the end of 2026.
Under federal and state WARN requirements, major employers provide advance notice ahead of qualifying mass layoffs or site closures. The latest filing indicates that the 215 Plainsboro reductions are slated to take effect in mid-February.
Details on which specific roles or divisions in Plainsboro are impacted by the February round were not immediately clear from the summary notes.